| LMT |
Report |
EPS (Q2'26, non-GAAP/ex-charge) |
MISS |
pred ~$6.95 vs. cons $7.15 |
MEDIUM |
| LMT |
Report |
Revenue (Q2'26) |
MISS |
pred ~$19.0B vs. cons $19.28B |
LOW |
| LMT |
Report |
Segment operating margin (Q2'26) |
MISS |
pred ~10.2% vs. cons ~10.7% |
MEDIUM |
| LMT |
Guide |
FY26 EPS guide |
UNCHANGED |
guide ~$29.35-30.25 (mid ~$29.80) vs. cons ~$29.75 (FY26) |
MEDIUM |
| LMT |
Guide |
FY26 Free Cash Flow guide |
UNCHANGED |
guide ~$6.5-6.8B (top-end lean) vs. cons ~$6.7B (FY26) |
MEDIUM |
| LMT |
Guide |
FY26 Sales guide |
UNCHANGED |
guide ~$77.5-80.0B (mid ~$78.75B) vs. cons ~$78.7B (FY26) |
MEDIUM |
| LMT |
Guide |
Backlog / book-to-bill (THAAD ~$35B, PAC-3) |
BETTER |
guide backlog ~$200B+ vs. prior $186B / cons ~$190B (Q2'26) |
MEDIUM |
| LMT |
Guide |
Classified program charges (Aero/MFC) & new-CEO big-bath risk |
UNKNOWN |
guide charge ~$0 (cash burn ~$500-700M/yr) vs. cons $0 charge (FY26) |
LOW |
| LMT |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.0% |
— |
MEDIUM |
| LMT |
Return |
5-day cumulative residual |
-4.5% (FOLLOW-THROUGH) |
Setup is a high-bar 'clean comp' with a fresh CEO (St. John) print — elevated big-bath/charge risk plus a demanding +6% revenue reaccel off a flat, sub-11% margin Q1. A soft Q2 on margin/FCF with only a reaffirmed (not raised) FY guide forces sell-side to trim out-period H2 estimates even if the headline is 'clean,' because the ~+25% segment-profit bridge becomes harder. Low-beta name (~0.5) so residual is idiosyncratic; skeptical, drifting-lower positioning means a miss/charge pulls estimates and the stock lower over the week rather than reversing. Offsetting bull case (record THAAD/PAC-3 bookings, positive FCF vs easy year-ago -$150M comp) caps downside but is unlikely to spark durable follow-through given execution doubts. |
LOW |